Crinetics Pharmaceuticals SG&A Expense (Semi Annual) Analysis

Crinetics Pharmaceuticals, Inc. (CRNX)

37.71 +0.48 (+1.29%) USD | NASDAQ | Apr 06, 16:00

37.71 0.00 (0.00%) After-Hours: 17:09

View SG&A Expense (Semi Annual) for CRNX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Semi Annual) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Semi Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Semi Annual) Benchmarks

Start Trial

Plus Therapeutics, Inc.	--
Nektar Therapeutics	--
Madrigal Pharmaceuticals, Inc.	--
Axsome Therapeutics, Inc.	--
Gossamer Bio, Inc.	--